Read news on Inbiomotion with our app.
Read more in the app
Inbiomotion’s MAF Test® now available to early-stage breast cancer patients in the United States through NeoGenomics
Inbiomotion, the spin-off of IRB Barcelona and ICREA, has signed an agreement to take the MAF Test® to patients in South Korea - EurekAlert!